Pokey, I fully agree with you. Of course, we all expected

New Post Public Reply Private Reply Replies (0) Message Board
Zolis_onkel Pokey123 #26261
413
Pokey,
I fully agree with you. Of course, we all expected major news to come out in the time between the CC announcement and the CC yesterday. When the news did not show up ahead of the CC, all I read on here was "Joe is saving all his ammunition for the CC".
Then the first thing he says is "I can't say much, due to quiet period" Duh, what are we having a CC for then? To receive a biochemistry lecture by RP, who sounded as if he was almost falling asleep while telling us how excited he was about the lab tests, only to conclude that "we don't know for sure yet, but things look promising"?
Quiet period? It seems that Joe was more open to give out information in his recent interview (The Wize Oz, or whatever it was called) than he was able or willing to say to us shareholders directly yesterday.
Why in this world does everything always seems to take longer than expected, when it comes to GNBT? Have they noticed that this is a race - no longer for the first - bitte maybe the best vaccine out there, and that it sometimes takes running to win a race, while it seems they continue to have a walk in the park?
And even if there were YET ADDITIONAL delays, why do they still hold the CC basically with little to nothing substantial to show for? Why not postpone the CC until they finally have the final results that they can discuss with us? I left work early, here in Germany, to be able to participate in this call, for THIS?
And finally to this statement I read here all over the place, especially after the CC "we have to be patient just a little bit longer". Well, I can't hear this anymore, as patience is what I have shown for more than ONE ENTIRE YEAR already. Patient I have been for the last 4 week, between the announcement and the CC, waiting for the big news to show up. NOTHING, except for a share price that dropped back to the levels I thought we had left for good a couple of weeks ago. So yes, Pokey, I agree, I also feel like a donkey with a carrot dangling in front of its nose, to always keep walking.
Didn't the most of us kept stating on here recently that it is "show me" time for GNBT now? How does that fit into the reiterated "be patient" statements now?
Sorry, but I am still very frustrated after this CC that I went into full of positive expectations, only to be disappointed again.
This is still one of the largest positions in my brokerage account, but still one of the worst performers, just because I am already a long time investor, and I have made - what turns out to be - the mistake and purchased a majority of my shares not at the very bottom, but I have been patient, and was barely (30%) above the water level before the CC started, and now I am back in the red zone, while other investments have given me several 100% of gains already, even though most of them are in my depot only a fraction of the time. So where the heck is my reward for being patient for such a long time???
This is really frustrating to say least, but I will stop my rant now.
Everyone have a good weekend, as much as it is possible after such a bummer to start it off with. I really hope that they are doing what a lot of folks on here asked for and come up with a summary PR early next week to emphasize on all the great things that they have going.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Allison Ng Earns Prestigious NAPABA 'Best Under 40' Award

Updated Category News Views 1

Allison Ng's Achievement: Beyond the Legal Grind Without warning, the legal world has another star rising up through its ranks, and this time it's Allison Ng catching the spotlight. She’s tucked away in Greenberg Traurig’s Atlanta office, plugging away in pharmaceutical and medical device litigation. But every now and then, these legal eagles get a chance to spread...

Continue Reading
King Risk Partners Expands Mid-Atlantic Presence Boldly

Updated Category News Views 1

King Risk Partners Grows with New Jersey Acquisition You don't get far in the insurance game without making some bold moves, and King Risk Partners just made a big one—sweeping into New Jersey. They've snagged Conover Beyer Associates Insurance, a firm that's been around longer than some European countries. It's not every day you buy a piece of history, but that's...

Continue Reading
Transamerica Reinforces Leadership for Retirement Expansion

Updated Category News Views 3

Transamerica's Next Phase: Leadership Moves in Retirement Transamerica just pulled a move that’s both bold and calculated. They’ve beefed up their retirement distribution squad with Danny Kling and Kevin Murphy stepping into the spotlight. These guys are bringing heaps of experience and a fresh jolt of energy to keep the momentum going. No doubt this is Transamerica...

Continue Reading
Innovative Lighting Idea Brightens Indoor Lives

Updated Category News Views 3

Shedding Light on SUN ORB's Indoor Revolution Sometimes, the best ideas come from simple needs, like wanting a bit of sunshine in your life. That's the deal with this SUN ORB concept—an invention dreamed up by a chap from Oklahoma who's spent too much time away from the natural light outside. We're talking about a wellness-oriented lighting idea that has big ambitions...

Continue Reading
Pentair Faces Class Action Over Fraud Allegations

Updated Category News Views 2

Catastrophe Strikes Pentair Ah, the sweet sound of a lawsuit hammering down on Wall Street—a routine part of corporate life for some of the biggest players in the game. This time, the bell tolls for Pentair plc, and it ain't pretty, folks. News just dropped that investors in New York Stock Exchange: PNR are staring down a newly expanded securities fraud class action...

Continue Reading
Money Market Funds Surge to Record $7.98 Trillion

Updated Category News Views 4

When Money Talks Fast: Market Funds Smash Records Picture this: money market funds have surged to an eye-watering $7.98 trillion. That's a lot of zeros, folks. And it's not just the usual humdrum growth; we're talking a hefty $44.75 billion increase in just one week, thanks to a cocktail of government funds and prime fund muscle, as the Investment Company Institute (ICI)...

Continue Reading
Windows Storage Trends Shift: SSD Dominates 2026

Updated Category News Views 2

SSDs Take Center Stage in Storage Evolution Howdy, storage folks! It's 2026, and one thing's for sure—SSDs are strutting their stuff at the top of the storage heap. According to the latest report by EaseUS Software, the dominant drive isn't about sheer size anymore. We've moved on to smarter space management. Now hear this: 79.73% of Windows system drives are rocking...

Continue Reading
Agroz: Awards Fuel Momentum in AgriTech Sphere

Updated Category News Views 0

Agroz Surging Ahead with Global Acclaim There's a new breeze blowing through the AgTech industry, and it's carrying Agroz Inc. (NASDAQ: AGRZ) straight to the top. Fresh off the back of snagging several prestigious international awards, this vertically integrated agricultural tech powerhouse is making waves not just in Malaysia, but on the global stage. Top of the FoodTech...

Continue Reading
Aurzen Leverages Basquiat for Art-Infused Projection Line

Updated Category News Views 2

A Fresh Perspective on Portable Projection If anyone had told me a tech brand would buddy up with the world of fine art to launch a new gadget line, I'd have raised an eyebrow. But here we are, shrugging away the standard and looking at what's cooking over at Aurzen. The company's new initiative, 'Unfold the Art,' marries the magnetism of Jean-Michel Basquiat's artwork...

Continue Reading
Patti Humble Joins EWA, Strengthens Female Leadership

Updated Category News Views 1

Strengthening the Network: Patti Humble Joins EWA Seeing Patti Humble lace up her boots and march into the Exceptional Women Alliance (EWA) is like watching a seasoned chess master find her tournament. Over decades, Humble's built a reputation as a linchpin in the corporate finance world, weathering transformations, mergers, and industry shifts that'd make a lesser-known...

Continue Reading

Top 5 Most Recently Viewed Articles

Lanvin Group's Anticipated 2024 Revenue Release Details

Updated Category News Views 101

Lanvin Group to Unveil 2024 Revenue Results Lanvin Group (NYSE: LANV), a prominent name in the luxury fashion industry, is gearing up to announce its preliminary revenues for 2024. The event will be significant for investors and market enthusiasts alike, as it will provide insights into the group’s growth trajectory and market positioning. Conference Call Scheduled for...

Continue Reading
iRhythm Technologies Unveils Groundbreaking Heart Monitoring Insights

Updated Category News Views 237

New Insights in Heart Monitoring iRhythm Technologies, Inc. (NASDAQ: IRTC), has revealed pivotal findings through a significant study published in Heart Rhythm. This recent analysis highlights the importance and effectiveness of their Zio long-term continuous monitoring (LTCM) service over traditional monitoring methods, particularly addressing actionable arrhythmias in...

Continue Reading
Exploring Human Behavior in National Geographic's Latest Series

Updated Category News Views 55

Unveiling the Stanford Prison Experiment: A Deep Dive into Human Nature National Geographic has premiered an intriguing trailer for their upcoming docuseries, THE STANFORD PRISON EXPERIMENT: UNLOCKING THE TRUTH, set to air soon. This three-part series, directed by Juliette Eisner and produced by Muck Media, will provide insights into one of psychology's most notorious...

Continue Reading
SpringWorks Therapeutics Shares Insight on Q4 2024 Performance

Updated Category News Views 422

SpringWorks Therapeutics Reflects on Fourth Quarter and 2024 Achievements SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a biopharmaceutical company dedicated to treating severe rare diseases and cancer, has reported strong preliminary fourth quarter and full year financial results for 2024. The company achieved notable U.S. net product revenues of $61.5 million in the...

Continue Reading
Frisco Economic Development Corporation Cultivates Venture Capital

Updated Category News Views 173

Frisco Economic Development Corporation Cultivates Venture Capital In an exciting development for the entrepreneurial landscape, the Frisco Economic Development Corporation (FEDC) has announced the appointment of Jon Nordby as the inaugural Venture Capitalist in-Residence (VCiR). This unique initiative is part of a larger four-pillar innovation strategy designed to...

Continue Reading